R1	Has_temporal Arg1:T2 Arg2:T3	
R2	Has_temporal Arg1:T1 Arg2:T4	
*	OR T5 T6
R3	Subsumes Arg1:T2 Arg2:T5	
R4	Has_context Arg1:T10 Arg2:T9	
R5	Has_context Arg1:T9 Arg2:T11	
*	OR T1 T10 T2 T8
R6	Has_qualifier Arg1:T12 Arg2:T14	
R7	Has_qualifier Arg1:T12 Arg2:T17	
*	OR T24 T23
R8	Subsumes Arg1:T22 Arg2:T24	
R9	AND Arg1:T28 Arg2:T26	
R10	Has_qualifier Arg1:T19 Arg2:T29	
R11	Has_qualifier Arg1:T20 Arg2:T31	
*	OR T21 T22
R12	Subsumes Arg1:T20 Arg2:T21	
*	OR T19 T20
R13	Has_temporal Arg1:T35 Arg2:T36	
R14	Has_temporal Arg1:T37 Arg2:T36	
*	OR T35 T37
R15	Subsumes Arg1:T38 Arg2:T39	
R16	Has_index Arg1:T42 Arg2:T43	
R17	Has_qualifier Arg1:T45 Arg2:T47	
R18	AND Arg1:T47 Arg2:T46	
R19	Has_index Arg1:T48 Arg2:T49	
R20	Has_context Arg1:T45 Arg2:T44	
R21	Has_temporal Arg1:T45 Arg2:T48	
R22	Has_index Arg1:T51 Arg2:T52	
R23	Has_temporal Arg1:T50 Arg2:T51	
R24	Has_temporal Arg1:T53 Arg2:T54	
*	OR T55 T57 T56
R25	Has_temporal Arg1:T55 Arg2:T58	
R26	Has_value Arg1:T60 Arg2:T62	
R27	Has_temporal Arg1:T60 Arg2:T61	
R28	Has_value Arg1:T66 Arg2:T67	
R29	Subsumes Arg1:T65 Arg2:T66	
R30	Has_qualifier Arg1:T64 Arg2:T65	
R31	Has_value Arg1:T70 Arg2:T71	
R32	Has_value Arg1:T68 Arg2:T69	
*	OR T68 T70
R33	Has_value Arg1:T72 Arg2:T73	
R34	Has_temporal Arg1:T72 Arg2:T74	
R35	Has_index Arg1:T74 Arg2:T75	
R36	Has_index Arg1:T77 Arg2:T78	
R37	Has_temporal Arg1:T76 Arg2:T77	
R38	Has_qualifier Arg1:T13 Arg2:T14	
R39	Has_qualifier Arg1:T13 Arg2:T17	
R40	Subsumes Arg1:T38 Arg2:T40	
T1	Condition 10 32	thromboembolic disease
T2	Condition 45 67	thromboembolic disease
T3	Temporal 34 41	history
T4	Temporal 3 9	Active
T5	Condition 79 91	retinal vein
T6	Condition 95 111	artery occlusion
T8	Condition 120 143	inherited thrombophilia
T9	Observation 148 162	family history
T10	Condition 166 176	thrombosis
T11	Observation 177 203	in a first degree relative
T12	Condition 240 259	psychiatric illness
T13	Condition 229 236;252 259	medical illness
T14	Qualifier 222 228	severe
T16	Undefined_semantics 222 228	severe
T17	Qualifier 266 343	in the opinion of the Investigator, would affect subject safety or compliance
T18	Non-query-able 266 343	in the opinion of the Investigator, would affect subject safety or compliance
T19	Condition 376 393	bleeding disorder
T20	Condition 414 432	bleeding disorders
T21	Condition 441 470	type 1 von Willebrand disease
T22	Condition 472 502	mild platelet function defects
T23	Condition 511 532;544 551	platelet storage pool defects
T24	Condition 511 519;536 551	platelet release defects
T26	Condition 587 609	Ehlers Danlos syndrome
T27	Grammar_Error 610 626	WILL be eligible
T28	Condition 571 579	bleeding
T29	Qualifier 369 375	severe
T30	Undefined_semantics 369 375	severe
T31	Qualifier 409 413	mild
T32	Undefined_semantics 409 413	mild
T35	Condition 660 669	Pregnancy
T36	Temporal 670 694	within the past 6 months
T37	Condition 702 716	breast-feeding
T38	Procedure 728 750	hormonal contraception
T39	Drug 752 760	estrogen
T40	Drug 765 774	progestin
T42	Temporal 776 806	within 3 months of study entry
T43	Reference_point 795 806	study entry
T44	Observation 811 827	anticipated need
T45	Procedure 840 882	estrogen-containing hormonal contraception
T46	Drug 840 848	estrogen
T47	Qualifier 840 859	estrogen-containing
T48	Temporal 883 906	during the study period
T49	Reference_point 890 906	the study period
T50	Drug 918 935	systemic steroids
T51	Temporal 936 965	within 1 month of study entry
T52	Reference_point 954 965	study entry
T53	Condition 981 1004	subarachnoid hemorrhage
T54	Temporal 970 977	History
T55	Condition 1020 1031	Hepatitis B
T56	Condition 1020 1029;1033 1034	Hepatitis C
T57	Condition 1039 1042	HIV
T58	Temporal 1009 1016	History
T60	Measurement 1056 1066	creatinine
T61	Temporal 1047 1055	Baseline
T62	Value 1067 1111	>20% above the upper limit of normal for age
T63	Person 1108 1111	age
T64	Condition 1124 1130	anemia
T65	Qualifier 1117 1123	Severe
T66	Measurement 1132 1142	hemoglobin
T67	Value 1143 1150	<8 g/dL
T68	Measurement 1157 1180	Systolic blood pressure
T69	Value 1181 1184	<85
T70	Measurement 1188 1212	diastolic blood pressure
T71	Value 1213 1216	<55
T72	Measurement 1222 1232	Heart rate
T73	Value 1233 1236	<50
T74	Temporal 1237 1257	at time of screening
T75	Reference_point 1240 1257	time of screening
T76	Device 1270 1286	intranasal DDAVP
T77	Temporal 1287 1300	during menses
T78	Reference_point 1294 1300	menses
T79	Grammar_Error 1301 1318	will be permitted
T80	Grammar_Error 1263 1726	Use of intranasal DDAVP during menses will be permitted, but only if the patient has a history of using DDAVP consistently for ≥3 menstrual cycles prior to study enrollment, so that change in menstrual blood loss due to addition of Lysteda can be assessed. Use of one-time DDAVP during a DDAVP/Stimate challenge is also permitted during the study period, as is use of DDAVP in the event of severe epistaxis, trauma, or surgical procedures during the study period.
T81	Not_a_criteria 1263 1725	Use of intranasal DDAVP during menses will be permitted, but only if the patient has a history of using DDAVP consistently for ≥3 menstrual cycles prior to study enrollment, so that change in menstrual blood loss due to addition of Lysteda can be assessed. Use of one-time DDAVP during a DDAVP/Stimate challenge is also permitted during the study period, as is use of DDAVP in the event of severe epistaxis, trauma, or surgical procedures during the study period
